Clinical Trial Update: Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain [Phase 1]

View source ↗

Summary

Phase 1 study evaluating Carmustine plus O6-benzylguanine in patients with recurrent or progressive gliomas of the brain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Carmustine (carmustine)
• O6-Benzylguanine (O6-Benzylguanine)

Snippet

Sponsor: Duke University | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED